Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Solutions
Drug Development
Pulmonary Interventions
Therapeutic Areas
COPD
Bronchiectasis Disease
Severe Asthma
Cystic Fibrosis
Technology
Evidence & Expertise
Publications
Research Projects
Advisory Board
Company
About Us
Events
Quality & Compliance
News
Career
Contact
Let's talk
Lung vascular volumes in cystic fibrosis patients before and after Elexacaftor-Tezacaftor-Ivacaftor (ETI) therapy
Source:
European Respiratory Journal (ERS Congress)
Publication link
